C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2009
12/31/2009	US20090326246 Method for Production of Optically Active 3-Amino-Nitrogenated Compound
12/31/2009	US20090326240 Iron-Copper Co-Catalyzed Process for Carbon-Carbon or Carbon-Heteroatom Bonding
12/31/2009	US20090326038 Method for treating a immunology-related disease
12/31/2009	US20090325962 Tyrosine derivative
12/31/2009	US20090325916 5-aryl indan-1-one and analogs useful as progesterone receptor modulators
12/31/2009	US20090325833 Lubricating oil additive and lubricating oil composition containing same
12/31/2009	US20090325832 Lubricating oil additive and lubricating oil composition containing same
12/31/2009	US20090325262 Immobilization of biological molecules onto surfaces coated with monolayers
12/31/2009	US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/31/2009	US20090324511 Compounds, Compositions and Methods
12/31/2009	US20090323508 Photosensitized composite material, three-dimensional memory material and recording medium, optical power limiting material and element, and photocuring material and stereolithography system, and fluorescent material for multiphoton fluorescence microscope and multiphoton fluorescence microscope
12/30/2009	WO2009157418A1 Carboxylic acid compound
12/30/2009	WO2009157005A1 Crystalline forms of atorvastatin hemi-magnesium salt and a process thereof
12/30/2009	WO2009156889A1 Diaryl compounds and uses thereof
12/30/2009	WO2009086303A3 Method for altering the lifespan of eukaryotic organisms
12/30/2009	EP2137146A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
12/30/2009	EP2029541B1 Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids
12/30/2009	EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases
12/30/2009	EP1562949B1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
12/30/2009	CN101616893A Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
12/30/2009	CN101613312A Method for preparing atorvastatin calcium
12/30/2009	CN100575340C High-molecular cross-linked polymer and its preparation method
12/30/2009	CN100575330C Novel compounds
12/30/2009	CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009	CA2727573A1 Diaryl compounds and uses thereof
12/30/2009	CA2727340A1 Carboxylic acid compound
12/29/2009	US7638639 Substituted pyrrolidine and related compounds
12/29/2009	US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/29/2009	US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors
12/29/2009	US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009	US7638549 Mitotic kinesin inhibitors
12/29/2009	US7638547 acaricidal, insecticidal agent both for animals and plants
12/29/2009	US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009	CA2443019C Kappa-opiate agonists for the treatment of bladder diseases
12/29/2009	CA2347763C Method of lithiating five-membered heterocycles
12/29/2009	CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules
12/24/2009	US20090318708 2-Oxo-1-Pyrrolidine Derivatives, Processes For Preparing Them And Their Uses
12/24/2009	US20090318693 Ligands for estrogen related receptors and methods for synthesis of said ligands
12/24/2009	US20090318525 Process For Preparing A 3-Pyrrole Substituted 2-Indolinone Malate Salt
12/24/2009	US20090318495 Ethenyl carboxamide derivatives useful as microbiocides
12/24/2009	US20090314660 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin
12/23/2009	WO2009155309A1 Substituted cyanopyrrolidine derivatives
12/23/2009	WO2009153649A1 Process for preparing 3-substituted pyrrolidine compounds
12/23/2009	WO2009153516A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153178A2 Aryl ketone as mri
12/23/2009	WO2009152824A1 Heterocyclic derivatives as iap binding compounds
12/23/2009	WO2009090251A3 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives
12/23/2009	EP2134681A1 Trans-annular rearrangement of active lactames
12/23/2009	EP1506169B1 Method for the production of sulphonic acid diamides
12/23/2009	EP1485343B1 Amorphous hmg-coa reductase inhibitors of desired particle size
12/23/2009	CA2728373A1 Aryl ketone as mri
12/23/2009	CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	CA2727626A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/22/2009	US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid
12/22/2009	CA2418538C Antibacterial mutilins
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/17/2009	WO2009152356A2 Compounds and compositions useful for the treatment of malaria
12/17/2009	WO2009151152A1 Oxycarbamoyl compounds and the use thereof
12/17/2009	WO2009150523A1 Process for preparing a 3-pyrrole substituted 2-indolinone malate salt
12/17/2009	WO2009150381A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same
12/17/2009	WO2009150248A1 Compounds which can be used for the treatment of cancers
12/17/2009	WO2009150075A1 Method for producing n-vinylpyrrolidone in a stainless steel reactor
12/17/2009	WO2009114950A8 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
12/17/2009	US20090312560 Processes for making pregabalin and intermediates therefor
12/17/2009	US20090312530 Processes for the convergent synthesis of calicheamicin derivatives
12/17/2009	US20090312519 Bismaleamic acid, bismaleimide and cured product thereof
12/17/2009	US20090312392 Amino ceramide-like compounds and therapeutic methods of use
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists
12/17/2009	US20090312341 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
12/17/2009	CA2727296A1 Compounds which can be used for the treatment of cancers
12/17/2009	CA2726158A1 Compounds and compositions useful for the treatment of malaria
12/17/2009	CA2725093A1 Azacarboline derivatives, preparation method thereof and therapeutic us of same
12/16/2009	EP2133384A2 Bismaleamic acid, bismaleimide and cured product thereof
12/16/2009	EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes
12/16/2009	EP2133330A1 Atropisomer of pyrrole derivative
12/16/2009	EP2132171A1 Novel crystal forms of pyrrolylheptanoic acid derivatives
12/16/2009	EP1805165B1 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists
12/16/2009	EP1737812B1 Methods of amination
12/16/2009	EP1284962B1 Method for obtaining pure n-vinyl pyrrolidone
12/16/2009	EP0848704B2 Form iii crystalline ¬r-(r,r) -2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-¬(phenylamino)carbonyl -1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
12/16/2009	CN101602704A Bismaleamic acid, bismaleimide and cured product thereof
12/16/2009	CN101602703A Pyrrole group-containing compound and preparation method and application thereof
12/16/2009	CN100569749C Production of 4-carbonyl-(S)-proline derivative
12/16/2009	CN100569748C Method for purifying 18F-Fallypride marker precursor compound
12/16/2009	CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
12/16/2009	CN100569736C Process for producing amino acid derivatives
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009	US7632858 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly
12/15/2009	US7632857 Histamine H3 receptor agents, preparation and therapeutic uses
12/15/2009	US7632576 Aryl-aryl dendrimers
12/15/2009	CA2607940C Bir domain binding compounds
12/15/2009	CA2482917C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
12/15/2009	CA2374580C Oligomers and polymers of cyclic imino carboxylic acids
12/15/2009	CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/15/2009	CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009	WO2009148599A1 Pyrrole compunds that modulate hsp90 activity
12/10/2009	WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009	WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers

1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 404